skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: EZB Electronic Journals Library remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Tumor-Infiltrating Natural Killer Cells
Tumor-Infiltrating Natural Killer Cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor-Infiltrating Natural Killer Cells

Cózar, Beatriz ; Greppi, Marco ; Carpentier, Sabrina ; Narni-Mancinelli, Emilie ; Chiossone, Laura ; Vivier, Eric

Cancer discovery, 2021-01, Vol.11 (1), p.34-44

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
2
TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma
TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma

Biton, Jérôme ; Mansuet-Lupo, Audrey ; Pécuchet, Nicolas ; Alifano, Marco ; Ouakrim, Hanane ; Arrondeau, Jennifer ; Boudou-Rouquette, Pascaline ; Goldwasser, François ; Leroy, Karen ; Goc, Jeremy ; Wislez, Marie ; Germain, Claire ; Laurent-Puig, Pierre ; Dieu-Nosjean, Marie-Caroline ; Cremer, Isabelle ; Herbst, Ronald ; Blons, Hélène ; Damotte, Diane

Clinical cancer research, 2018-11, Vol.24 (22), p.5710-5723 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
3
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Marabelle, Aurelien ; Le, Dung T ; Ascierto, Paolo A ; Di Giacomo, Anna Maria ; De Jesus-Acosta, Ana ; Delord, Jean-Pierre ; Geva, Ravit ; Gottfried, Maya ; Penel, Nicolas ; Hansen, Aaron R ; Piha-Paul, Sarina A ; Doi, Toshihiko ; Gao, Bo ; Chung, Hyun Cheol ; Lopez-Martin, Jose ; Bang, Yung-Jue ; Frommer, Ronnie Shapira ; Shah, Manisha ; Ghori, Razi ; Joe, Andrew K ; Pruitt, Scott K ; Diaz, Jr, Luis A

Journal of clinical oncology, 2020-01, Vol.38 (1), p.1-10 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

Finn, Richard S ; Ryoo, Baek-Yeol ; Merle, Philippe ; Kudo, Masatoshi ; Bouattour, Mohamed ; Lim, Ho Yeong ; Breder, Valeriy ; Edeline, Julien ; Chao, Yee ; Ogasawara, Sadahisa ; Yau, Thomas ; Garrido, Marcelo ; Chan, Stephen L ; Knox, Jennifer ; Daniele, Bruno ; Ebbinghaus, Scot W ; Chen, Erluo ; Siegel, Abby B ; Zhu, Andrew X ; Cheng, Ann-Lii

Journal of clinical oncology, 2020-01, Vol.38 (3), p.193-202 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

Houillier, Caroline ; Taillandier, Luc ; Dureau, Sylvain ; Lamy, Thierry ; Laadhari, Mouna ; Chinot, Olivier ; Molucon-Chabrot, Cecile ; Soubeyran, Pierre ; Gressin, Remy ; Choquet, Sylvain ; Damaj, Gandhi ; Thyss, Antoine ; Abraham, Julie ; Delwail, Vincent ; Gyan, Emmanuel ; Sanhes, Laurence ; Cornillon, Jerome ; Garidi, Reda ; Delmer, Alain ; Tanguy, Marie-Laure ; Al Jijakli, Ahmad ; Morel, Pierre ; Bourquard, Pascal ; Moles, Marie-Pierre ; Chauchet, Adrien ; Gastinne, Thomas ; Constans, Jean-Marc ; Langer, Adriana ; Martin, Antoine ; Moisson, Patricia ; Lacomblez, Lucette ; Martin-Duverneuil, Nadine ; Delgadillo, Daniel ; Turbiez, Isabelle ; Feuvret, Loic ; Cassoux, Nathalie ; Touitou, Valerie ; Ricard, Damien ; Hoang-Xuan, Khe ; Soussain, Carole

Journal of clinical oncology, 2019-04, Vol.37 (10) [Periódico revisado por pares]

American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast Cancer

Tolaney, Sara M ; Sahebjam, Solmaz ; Le Rhun, Emilie ; Bachelot, Thomas ; Kabos, Peter ; Awada, Ahmad ; Yardley, Denise ; Chan, Arlene ; Conte, Pierfranco ; Diéras, Véronique ; Lin, Nancy U ; Bear, Melissa ; Chapman, Sonya C ; Yang, Zhengyu ; Chen, Yanyun ; Anders, Carey K

Clinical cancer research, 2020-10, Vol.26 (20), p.5310-5319 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
7
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

Timperi, Eleonora ; Gueguen, Paul ; Molgora, Martina ; Magagna, Ilaria ; Kieffer, Yann ; Lopez-Lastra, Silvia ; Sirven, Philemon ; Baudrin, Laura G. ; Baulande, Sylvain ; Nicolas, André ; Champenois, Gabriel ; Meseure, Didier ; Vincent-Salomon, Anne ; Tardivon, Anne ; Laas, Enora ; Soumelis, Vassili ; Colonna, Marco ; Mechta-Grigoriou, Fatima ; Amigorena, Sebastian ; Romano, Emanuela

Cancer research (Chicago, Ill.), 2022-09, Vol.82 (18), p.3291-3306 [Periódico revisado por pares]

American Association for Cancer Research

Texto completo disponível

Citações Citado por
8
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes
Material Type:
Artigo 		Adicionar ao Meu Espaço

miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes

Croset, Martine ; Pantano, Francesco ; Kan, Casina W S ; Bonnelye, Edith ; Descotes, Françoise ; Alix-Panabières, Catherine ; Lecellier, Charles-Henri ; Bachelier, Richard ; Allioli, Nathalie ; Hong, Saw-See ; Bartkowiak, Kai ; Pantel, Klaus ; Clézardin, Philippe

Cancer research (Chicago, Ill.), 2018-09, Vol.78 (18), p.5259-5273 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
9
LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity
LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity
Material Type:
Artigo 		Adicionar ao Meu Espaço

LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity

Nioche, Christophe ; Orlhac, Fanny ; Boughdad, Sarah ; Reuzé, Sylvain ; Goya-Outi, Jessica ; Robert, Charlotte ; Pellot-Barakat, Claire ; Soussan, Michael ; Frouin, Frédérique ; Buvat, Irène

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (16), p.4786-4789 [Periódico revisado por pares]

United States: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Hutchings, Martin ; Morschhauser, Franck ; Iacoboni, Gloria ; Carlo-Stella, Carmelo ; Offner, Fritz C ; Sureda, Anna ; Salles, Gilles ; Martínez-Lopez, Joaquín ; Crump, Michael ; Thomas, Denise N ; Morcos, Peter N ; Ferlini, Cristiano ; Bröske, Ann-Marie E ; Belousov, Anton ; Bacac, Marina ; Dimier, Natalie ; Carlile, David J ; Lundberg, Linda ; Perez-Callejo, David ; Umaña, Pablo ; Moore, Tom ; Weisser, Martin ; Dickinson, Michael J

Journal of clinical oncology, 2021-06, Vol.39 (18), p.JCO2003175-1970 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (596.765)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (692.000)
  2. Resenhas  (100)
  3. magazinearticle  (22)
  4. Web Resources  (12)
  5. Anais de Congresso  (10)
  6. Livros  (1)
  7. Mais opções open sub menu

Assunto 

  1. Science & Technology  (691.193)
  2. Life Sciences & Biomedicine  (688.402)
  3. Humans  (388.963)
  4. Female  (210.246)
  5. Tumors  (167.821)
  6. Male  (161.273)
  7. Biological And Medical Sciences  (137.118)
  8. Middle Aged  (133.263)
  9. Medical Sciences  (127.785)
  10. Animals  (112.018)
  11. Aged  (109.452)
  12. Adult  (105.330)
  13. Cancer  (104.790)
  14. Prognosis  (79.601)
  15. Mice  (73.937)
  16. Chemotherapy  (72.160)
  17. Patients  (71.208)
  18. Metastasis  (67.729)
  19. Cell Line, Tumor  (61.651)
  20. Mais opções open sub menu

Idioma 

  1. Inglês  (691.990)
  2. Japonês  (95.453)
  3. Português  (1.493)
  4. Polonês  (856)
  5. Espanhol  (689)
  6. Norueguês  (407)
  7. Chinês  (388)
  8. Turco  (244)
  9. Russo  (187)
  10. Coreano  (62)
  11. Alemão  (50)
  12. Francês  (44)
  13. Esloveno  (27)
  14. Italiano  (11)
  15. Africâner  (6)
  16. Serbian  (1)
  17. Catalão  (1)
  18. Galês  (1)
  19. Sueco  (1)
  20. Dinamarquês  (1)
  21. Mais opções open sub menu

Nome da Publicação 

  1. Cancer Research  (45.020)
  2. Cancer  (38.731)
  3. Cancers  (26.666)
  4. Frontiers In Oncology  (25.383)
  5. British Journal Of Cancer  (22.926)
  6. Oncotarget  (20.765)
  7. Clinical Cancer Research  (19.339)
  8. International Journal Of Cancer  (17.511)
  9. Oncogene  (17.234)
  10. Bmc Cancer  (15.709)
  11. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.